Reuters/Ipsos poll: A quarter of Americans are hesitant about a coronavirus vaccine

Coronavirus vaccine development in India unlikely within a year say experts

At least six Indian firms are working on the development of COVID-19 vaccine

Only half of Americans (55%) say they would get vaccinated against the novel coronavirus, if and when a vaccine becomes available, according to a new YouGov survey.

Most respondents in the survey of 4,428 USA adults taken between May 13 and May 19 said they would be heavily influenced by guidance from the Food and Drug Administration or results of large-scale scientific studies showing that the vaccine was safe.

He said that the government had no other choice during the initial days of the COVID-19 outbreak to shut down. "I would have expected somewhere around 75%". "There is no company testing vaccine in India yet and they are in the pre-clinical stage of preparation", he said. There are also people who argue for herd immunity.

Naming the Indian firms working on vaccines for COVID-19, Gagandeep Kang, executive director of the Translational Health Science and Technology Institute, Faridabad, had said last month that while Zydus Cadila is working on two vaccines, Serum Institute, Biological E, Bharat Biotech, Indian Immunologicals, and Mynvax are developing one vaccine each.

Still, despite the encouraging data from Moderna, Fauci still thinks it will take 12 to 18 months for a coronavirus vaccine to be ready. The poll found that a quarter of Americans have little or no interest in being vaccinated against coronavirus. More than 40% said they believe the vaccine is riskier than the disease itself.

"If states and cities and counties are going to [open] no matter what, I would recommend that they take very specific precautions in doing that", he said. "If a comparison has to be made we are well behind global efforts", he said.

In addition, misinformation about vaccines has grown more prevalent on social media during the pandemic, according to academic researchers.

CSIR-Centre for Cellular & Molecular Biology (CCMB) Director Rakesh Mishra said, "From what we know, we are not at an advanced stage of vaccine development at the moment".

The poll underscores how the country's deepening polarization has affected people's view of the pandemic.

Another 26% said they were unsure about getting innoculated, while one in five said that they not get vaccinated at all.

Most of the survey's pollsters said they would be "heavily influenced by guidance from the Food and Drug Administration [FDA]".

The poll responses varied among certain demographic groups.

Earlier Friday, Fauci told NPR it is "conceivable" that the USA could have a coronavirus vaccine available by December.

College-educated white women - a politically important demographic that has moved sharply away from the Republican Party during the Trump era - were particularly concerned about how quickly the vaccine is being developed.

Form for signing up for free newsletter.

Latest News